AKT1 and neoplasm: Of note, one study compared the effect of blocking AKT versus PI3Kδ (a subset of PI3Ks) using mesothelin-specific CAR T cells and found that PI3Kδ inhibition upregulated the stem cell memory transcription factor TCF7 more than AKT inhibition, translating to better in vivo anti-tumor efficacy (56).